Upper bound on the mutational burden imposed by a CRISPR-Cas9 gene-drive element
Michael S Overton1, Sean E Guy1, Xingsen Chen1
1Department of Ecology, Behavior and Evolution, University of California San Diego, La Jolla, CA 92093, United States.
G3 (Bethesda, Md.)
|February 18, 2026
Summary
CRISPR-Cas9 gene drives (CCGDs) showed no detectable impact on mutation or loss-of-heterozygosity rates in yeast. These findings suggest CCGDs may pose acceptable evolutionary risks, warranting further study in other systems.
Area of Science:
- Genetics
- Molecular Biology
- Evolutionary Biology
Background:
- CRISPR-Cas9 gene drives (CCGDs) offer potential for population genetic control but raise safety concerns.
- Off-target DNA breaks by Cas9 could increase mutation rates and cause loss-of-heterozygosity (LOH).
- The magnitude of these unintended effects remains largely unknown.
Purpose of the Study:
- To quantify the impact of CCGDs and Cas9 on mutation and LOH rates.
- To assess the long-term evolutionary safety of gene drive systems.
Main Methods:
- Mutation accumulation experiment in yeast (Saccharomyces cerevisiae).
- Genome-wide analysis of de novo mutations and LOH events.
- Power calculations to determine effect size detection limits.
Main Results:
- No significant increase in genome-wide mutation or LOH rates was detected with CCGD or Cas9 presence.
- Power analysis indicated effects, if any, were less than 30%, below natural yeast variation.
- Potential alterations in LOH event characteristics were observed but lacked strong statistical support.
Conclusions:
- CCGDs impose a minimal additional mutational burden in yeast.
- Gene drive systems may present acceptable evolutionary risks.
- Further evaluation in diverse systems is recommended to confirm safety.
Related Concept Videos
CRISPR/Cas9 Genome Editing
2.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.1K
CRISPR
58.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.1K
CRISPR and crRNAs
19.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.3K
Homologous Recombination
64.1K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.1K


